期刊文献+

流感病毒即时检验研究进展

Research progress of Point-of-care testing of influenza virus
原文传递
导出
摘要 流行性感冒是由流感病毒引起的一种传播快、传染力强的人类呼吸道传染病,可在全球范围造成巨大的生命和财产损失。世界卫生组织已将开发针对呼吸道病毒的即时检验(POCT)列为优先事项。POCT对流感样患者进行快速、准确的诊断,对预防和控制流感病毒的传播以及减少重症病人的发生发展有重要意义。基于免疫学的流感病毒POCT快速、简便但灵敏度低,基于检测核酸的流感POCT方便快捷,弥补了免疫学POCT灵敏度低的缺点,未来通过优化成本效益可在临床POCT环境中大量应用。现对目前用于诊断流感病毒的正在应用和开发研究的POCT方法进行综述。 Influenza is a rapidly spreading and highly infectious human respiratory infectious disease caused by influenza viruses,which can cause huge loss of life and property on a global scale.The World Health Organization has prioritized the development of point-of-care testing(POCT)for respiratory viruses.The rapid and accurate diagnosis of influenza-like patients by POCT is of great significance for preventing and controlling the spread of influenza virus and reducing the occurrence and development of severely ill patients.Influenza POCT based on immunology is fast,simple but low sensitivity.Influenza POCT based on nucleic acid detection is convenient and quick,which makes up for the shortcomings of low sensitivity of immunology POCT.In the future,through optimization of cost-effectiveness,it can be applied in a large number of clinical immediate testing environments.This article summarizes the POCT methods that are currently being applied and developing diagnosis of influenza viruses.
作者 丁信 伍圣桢 杨子峰 关文达 Ding Xin;Wu Shengzhen;Yang Zifeng;Guan Wenda(First Affiliated Hospital of Guangzhou Medical University,Guangzhou Guangdong 510120,China;Guangzhou Key Laboratory For Clinical Rapid Diagnosis And Early Warning of Infectious Diseases KingMed School of Laboratory Medicine,Guangzhou Medical University,Guangzhou Guangdong 510182,China)
出处 《中华临床实验室管理电子杂志》 2022年第1期41-49,共9页 Chinese Journal of Clinical Laboratory Management(Electronic Edition)
基金 广州市科技局基础研究计划(202102100003)。
关键词 流感病毒 即时检验 Influenza virus Point-of-care testing
  • 相关文献

参考文献5

二级参考文献76

  • 1张德玺,韩洪彦,王希良.一种快速检测甲型流感病毒的方法[J].中国比较医学杂志,2007,17(1):42-45. 被引量:25
  • 2龚黎明,葛琼,卢亦愚,严菊英,周敏,李敏红.4种核酸提取方法在流行性感冒病毒核酸检测中的比较[J].中国卫生检验杂志,2007,17(1):53-54. 被引量:9
  • 3Tuerk C,Gold L.Systematic evolution of ligands by exponential enrichment:RNA ligands to bacteriophage T4 DNA polymerase[J].Science,1990,249(4968):505.
  • 4Ellingto A D,Szostak J W.In vitro selection of RNA molecules that bind specific ligands[J].Nature,1990,346(6287):8l8.
  • 5van-der-Vliet HN,Sammels MG,Leegwater AC,et al.Apolipoprotein A-V:anovel Apolipoprotein associated with an earlyphase of liver regeneration[J].J Biol Chem,2001,276(48):44512.
  • 6Pennacchio LA,Olivier M,Hubacek JA,et al.An Apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing[J].Science,2001,294(5540):169.
  • 7Camille L A Hamula,Jeffrey W Guthrie,Hongquan Zhang,et al.Selection and analytical applications of aptamers[J].TrAC Trends in An alytical Chemistry,2006,25(7):681.
  • 8Nimjee S M,Rusconi C P,Sullenger B A.Aptamers:an emersing class of therapeutics[J].Annu Rev Med,2005,56:555.
  • 9Kusser W.Chemically modified nucleic acid aptalners for in vifro selections:evolving evolution[J].J Biotechnol,2000,74(1):27.
  • 10Eyetech Study Group.Preclinical and phase 1 A clinical evaluation of an anti-VEGF pegylated aptamer(EYE001)for the treatment of exudative age-related macular degeneration[J].Retina,2002,22:143.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部